Genoprotective role of pembrolizumab liposome in isolated lymphocytes from head and neck squamous cell carcinoma patients compared to those from healthy individuals in vitro

References

• Alhawmdeh, M., M. Isreb, A. Aziz, B. K. Jacob, D. Anderson, and M. Najafzadeh. 2021. “Interferon-γ Liposome: A New System to Improve Drug Delivery in the Treatment of Lung Cancer.” ERJ Open Research 7 (3): 00555–2020. https://doi.org/10.1183/23120541.00555-2020
   PubMedGoogle Scholar
• Alhmoud, J. F., J. F. Woolley, A. E. Al Moustafa, and M. I. Malki. 2020. DNA Damage/Repair Management in Cancers. Cancers (Basel) 12 (4): 1050. https://doi.org/10.3390/cancers12041050
   Google Scholar
• Anderson, D., M. Najafzadeh, R. Gopalan, N. Ghaderi, A. J. Scally, S. T. Britland, B. K. Jacobs, et al. 2014. “Sensitivity and Specificity of the Empirical Lymphocyte Genome Sensitivity (LGS) Assay: implications for Improving Cancer Diagnostics.” FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology 28 (10): 4563–4570. https://doi.org/10.1096/fj.14-254748
   PubMed Web of Science ®Google Scholar
• Argiris, A., R. L. Ferris, and D. I. Rosenthal. 2018. Head and Neck Cancers: Evidence-Based Treatment. Springer Publishing Company.
   Google Scholar
• Barenholz, Y., and D. Peer. 2012. “Liposomes and Other Assemblies as Drugs and Nano-Drugs: From Basic and Translational Research to the Clinics.” Journal of Controlled Release: Official Journal of the Controlled Release Society 160 (2): 115–116. https://doi.org/10.1016/j.jconrel.2012.03.025
   PubMed Web of Science ®Google Scholar
• Bozzuto, G., and A. Molinari. 2015. “Liposomes as Nanomedical Devices.” International Journal of Nanomedicine 10: 975–999. https://doi.org/10.2147/IJN.S68861
   PubMed Web of Science ®Google Scholar
• Bray, F., J. Ferlay, I. Soerjomataram, R. L. Siegel, L. A. Torre, and A. Jemal. 2018. “Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.” CA: a Cancer Journal for Clinicians 68 (6): 394–424. https://doi.org/10.3322/caac.21492
   PubMed Web of Science ®Google Scholar
• Chen, Y., A. Geng, W. Zhang, Z. Qian, X. Wan, Y. Jiang, and Z. Mao. 2020. “Fight to the Bitter End: DNA Repair and Aging.” Ageing Research Reviews 64: 101154. https://doi.org/10.1016/j.arr.2020.101154
   PubMed Web of Science ®Google Scholar
• Cohen, E. E. W., D. Soulières, C. Le Tourneau, J. Dinis, L. Licitra, M.-J. Ahn, A. Soria, KEYNOTE-040 investigators, et al. 2019. “Pembrolizumab versus Methotrexate, Docetaxel, or Cetuximab for Recurrent or Metastatic Head-and-Neck Squamous Cell Carcinoma (KEYNOTE-040): a Randomised, Open-Label, Phase 3 Study.” Lancet (London, England) 393 (10167): 156–167. https://doi.org/10.1016/S0140-6736(18)31999-8
   PubMed Web of Science ®Google Scholar
• Deng, L., X. Ke, Z. He, D. Yang, H. Gong, Y. Zhang, X. Jing, J. Yao, and J. Chen. 2012. “A MSLN-Targeted Multifunctional Nanoimmunoliposome for MRI and Targeting Therapy in Pancreatic Cancer.” International Journal of Nanomedicine 7: 5053–5065. https://doi.org/10.2147/IJN.S34801
   PubMed Web of Science ®Google Scholar
• Dequanter, D., R. Dok, and S. Nuyts. 2017. “Basal Oxidative Stress Ratio of Head and Neck Squamous Cell Carcinomas Correlates with Nodal Metastatic Spread in Patients under Therapy.” OncoTargets and Therapy 10: 259–263. https://doi.org/10.2147/OTT.S118980
   PubMed Web of Science ®Google Scholar
• Fenech, M. 2007. “Cytokinesis-Block Micronucleus Cytome Assay.” Nature Protocols 2 (5): 1084–1104. https://doi.org/10.1038/nprot.2007.77
   PubMed Web of Science ®Google Scholar
• Francisco, L. M., P. T. Sage, and A. H. Sharpe. 2010. “The PD-1 Pathway in Tolerance and Autoimmunity.” Immunological Reviews 236 (1): 219–242. https://doi.org/10.1111/j.1600-065X.2010.00923.x
   PubMed Web of Science ®Google Scholar
• Frick, M., C. Schwieger, and C. Schmidt. 2021. “Liposomes as Carriers of Membrane-Associated Proteins and Peptides for Mass Spectrometric Analysis.” Angewandte Chemie (International ed. in English) 60 (20): 11523–11530. https://doi.org/10.1002/anie.202101242
   PubMed Web of Science ®Google Scholar
• Goldberg, S. B., S. N. Gettinger, A. Mahajan, A. C. Chiang, R. S. Herbst, M. Sznol, A. J. Tsiouris, et al. 2016. “Pembrolizumab for Patients with Melanoma or Non-Small-Cell Lung Cancer and Untreated Brain Metastases: early Analysis of a Non-Randomised, Open-Label, Phase 2 Trial.” The Lancet. Oncology 17 (7): 976–983. https://doi.org/10.1016/S1470-2045(16)30053-5
   PubMed Web of Science ®Google Scholar
• Johnson, D. E., B. Burtness, C. R. Leemans, V. W. Y. Lui, J. E. Bauman, and J. R. Grandis. 2020. “Head and Neck Squamous Cell Carcinoma.” Nature Reviews. Disease Primers 6 (1): 92. https://doi.org/10.1038/s41572-020-00224-3
   PubMed Web of Science ®Google Scholar
• Kroll, A., M. H. Pillukat, D. Hahn, and J. Schnekenburger. 2009. “Current in Vitro Methods in Nanoparticle Risk Assessment: limitations and Challenges.” European Journal of Pharmaceutics and Biopharmaceutics: official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik e.V 72 (2): 370–377. https://doi.org/10.1016/j.ejpb.2008.08.009
   PubMed Web of Science ®Google Scholar
• Kulaberoglu, Y., A. Hergovich, and V. Gómez. 2021. “The Role of p53/p21/p16 in DNA Damage Signaling and DNA Repair.” In Genome Stability, 257–274. Elsevier.
   Google Scholar
• Li, Y., D. H. Chen, J. Yan, Y. Chen, R. A. Mittelstaedt, Y. Zhang, A. S. Biris, R. H. Heflich, and T. Chen. 2012. “Genotoxicity of Silver Nanoparticles Evaluated Using the Ames Test and in Vitro Micronucleus Assay.” Mutation Research 745 (1–2): 4–10. https://doi.org/10.1016/j.mrgentox.2011.11.010
   PubMed Web of Science ®Google Scholar
• Michaud, D. S., S. M. Langevin, M. Eliot, H. H. Nelson, M. Pawlita, M. D. McClean, and K. T. Kelsey. 2014. “High-Risk HPV Types and Head and Neck Cancer.” International Journal of Cancer 135 (7): 1653–1661. https://doi.org/10.1002/ijc.28811
   PubMed Web of Science ®Google Scholar
• Raj, R., P. Mongia, S. Kumar Sahu, and A. Ram. 2016. “Nanocarriers Based Anticancer Drugs: Current Scenario and Future Perceptions.” Current Drug Targets 17 (2): 206–228. https://doi.org/10.2174/1389450116666150722141607
   PubMed Web of Science ®Google Scholar
• Schmid, P., R. Salgado, Y. H. Park, E. Muñoz-Couselo, S. B. Kim, J. Sohn, S.-A. Im, et al. 2020. “Pembrolizumab plus Chemotherapy as Neoadjuvant Treatment of High-Risk, Early-Stage Triple-Negative Breast Cancer: results from the Phase 1b Open-Label, Multicohort KEYNOTE-173 Study.” Annals of Oncology: Official Journal of the European Society for Medical Oncology 31 (5): 569–581. https://doi.org/10.1016/j.annonc.2020.01.072
   PubMed Web of Science ®Google Scholar
• Seiwert, T. Y., R. I. Haddad, S. Gupta, R. Mehra, M. Tahara, R. Berger, S.-H. Lee, B. Burtness, D. T. Le, and K. Heath. 2015. Antitumor Activity and Safety of Pembrolizumab in Patients (Pts) with Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN): Preliminary Results from KEYNOTE-012 Expansion Cohort. American Society of Clinical Oncology.
   Google Scholar
• Shah, S., V. Dhawan, R. Holm, M. S. Nagarsenker, and Y. Perrie. 2020. “Liposomes: Advancements and Innovation in the Manufacturing Process.” Advanced Drug Delivery Reviews 154–155: 102–122. https://doi.org/10.1016/j.addr.2020.07.002
   PubMed Web of Science ®Google Scholar
• Sundahl, N., S. Rottey, D. De Maeseneer, and P. Ost. 2018. “Pembrolizumab for the Treatment of Bladder Cancer.” Expert Review of Anticancer Therapy 18 (2): 107–114. https://doi.org/10.1080/14737140.2018.1421461
   PubMed Web of Science ®Google Scholar
• Sung, W. W., J. C. Chow, and W. C. Cho. 2021. “Tumor Mutational Burden as a Tissue-Agnostic Biomarker for Cancer Immunotherapy.” Expert Review of Clinical Pharmacology 14 (2): 141–143. https://doi.org/10.1080/17512433.2021.1865797
   PubMed Web of Science ®Google Scholar
• Toor, S., A. Syed Khaja, I. Alkurd, and E. Elkord. 2018. “In-Vitro Effect of Pembrolizumab on Different T Regulatory Cell Subsets.” Clinical and Experimental Immunology 191 (2): 189–197. https://doi.org/10.1111/cei.13060
   PubMed Web of Science ®Google Scholar